Yang C - Search Results

1

Mapping the landscape of synthetic lethal interactions in liver cancer.

Yang C, Guo Y, Qian R, Huang Y, Zhang L, Wang J, Huang X, Liu Z, Qin W, Wang C, Chen H, Ma X, Zhang D. Yang C, et al. Theranostics. 2021 Aug 26;11(18):9038-9053. doi: 10.7150/thno.63416. eCollection 2021. Theranostics. 2021. PMID: 34522226 Free PMC article.

2

Metabolism-associated molecular classification of hepatocellular carcinoma.

Yang C, Huang X, Liu Z, Qin W, Wang C. Yang C, et al. Mol Oncol. 2020 Apr;14(4):896-913. doi: 10.1002/1878-0261.12639. Epub 2020 Jan 29. Mol Oncol. 2020. PMID: 31955511 Free PMC article.

3

Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen.

Yang C, Chen J, Li Y, Huang X, Liu Z, Wang J, Jiang H, Qin W, Lv Y, Wang H, Wang C. Yang C, et al. Brief Bioinform. 2021 Jul 20;22(4):bbaa295. doi: 10.1093/bib/bbaa295. Brief Bioinform. 2021. PMID: 33167027

4

Exploring liver cancer biology through functional genetic screens.

Wang C, Cao Y, Yang C, Bernards R, Qin W. Wang C, et al. Among authors: yang c. Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):690-704. doi: 10.1038/s41575-021-00465-x. Epub 2021 Jun 23. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34163045 Review.

5

Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer.

Guo Y, Wang J, Benedict B, Yang C, van Gemert F, Ma X, Gao D, Wang H, Zhang S, Lieftink C, Beijersbergen RL, Te Riele H, Qiao X, Gao Q, Sun C, Qin W, Bernards R, Wang C. Guo Y, et al. Among authors: yang c. Genome Med. 2021 Oct 18;13(1):166. doi: 10.1186/s13073-021-00981-0. Genome Med. 2021. PMID: 34663432 Free PMC article.

6

Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy.

Li Y, Yang C, Liu Z, Du S, Can S, Zhang H, Zhang L, Huang X, Xiao Z, Li X, Fang J, Qin W, Sun C, Wang C, Chen J, Chen H. Li Y, et al. Among authors: yang c. Mol Cancer. 2022 Jan 2;21(1):2. doi: 10.1186/s12943-021-01462-z. Mol Cancer. 2022. PMID: 34980132 Free PMC article.

7

Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.

Liu Z, Lin D, Zhou Y, Zhang L, Yang C, Guo B, Xia F, Li Y, Chen D, Wang C, Chen Z, Leng C, Xiao Z. Liu Z, et al. Among authors: yang c. Sci Rep. 2022 Aug 2;12(1):13222. doi: 10.1038/s41598-022-16657-7. Sci Rep. 2022. PMID: 35918352 Free PMC article.

8

Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer.

Geng H, Qian R, Zhang L, Yang C, Xia X, Wang C, Zhao G, Zhang Z, Zhu C. Geng H, et al. Among authors: yang c. Aging (Albany NY). 2022 Aug 14;14(15):6358-6376. doi: 10.18632/aging.204227. Epub 2022 Aug 14. Aging (Albany NY). 2022. PMID: 35969182 Free PMC article.

9

Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology.

Yang C, Huang X, Li Y, Chen J, Lv Y, Dai S. Yang C, et al. Brief Bioinform. 2021 May 20;22(3):bbaa164. doi: 10.1093/bib/bbaa164. Brief Bioinform. 2021. PMID: 32789496

10

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment.

Zeng C, Zhang L, Luo C, Yang C, Huang X, Fan L, Li J, Chen F, Luo Z. Zeng C, et al. Among authors: yang c. BMC Cancer. 2022 Jun 4;22(1):613. doi: 10.1186/s12885-022-09647-5. BMC Cancer. 2022. PMID: 35659630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,722 results

Search Page

Filters